• Press Release

Scientists Show How Bone-Bordering Cells May Help Shape a Skull

Mount Sinai study of mice searched for the cells and genes that may orchestrate how skull bones are joined together

  • (December 09, 2021)

A skull is not one single bone but rather a collection of bone plates joined together early in development. In a study of mice, scientists at the Icahn School of Medicine at Mount Sinai showed how the activity of one gene, turned on in a newly discovered group of bone-bordering cells, may play an important role in shaping the skull. The skulls of mice that were missing the gene were misshapen and were depleted of the cells in a manner that is reminiscent of craniosynostosis, a developmental disorder that affects about one out every 2,500 babies born in the United States.

The lead author of the study was Greg Holmes, PhD, Assistant Professor of Genetics and Genomic Sciences at Icahn Mount Sinai.

The study focused on the cells of the coronal suture, a fibrous joint that connects the front and middle bone plates. In humans, it runs across the top of the skull, from one temple to the other. Throughout development, the suture is filled with a buffering tissue called mesenchyme, which contains stem cells. The stem cells provide a constant source of new bone cells, or osteoblasts, which are needed as the plates on either side grow and the skull expands. In adults, these stem cells are depleted and the joints between the bone plates fuse.

Craniosynostosis is a birth defect in which this fusion happens prematurely, resulting in babies born with misshapen skulls who may develop neurological problems. Scientists have shown that about 25 percent of cases are linked to genetic mutations and that normal suture development is controlled by a variety of growth factors. Of all the sutures needed to form a skull, the coronal suture is commonly affected in craniosynostosis.

In this study, the Holmes lab worked with researchers in the labs of Bin Zhang, PhD, Harm van Bakel, PhD, and Ethylin Wang Jabs, MD, of Icahn Mount Sinai. Together they studied how the genetic activity in the cells of the coronal suture changes during early development. To do this, they measured the RNA levels of individual suture cells from embryonic mice about one to three days before the mice were normally born.

Their results suggested that a gene encoding a molecule called hedgehog interacting protein (HHIP) plays a unique and critical role in coronal suture development. The gene was more active in a novel group of mesenchyme cells than it was in osteoblasts. In fact, the scientists saw the opposite trend when they looked at the cells of other sutures. Tracing experiments suggested that after birth the coronal suture osteoblasts were derived from these mesenchyme cells. Moreover, the skulls of embryonic mutant mice that were missing the HHIP gene were shaped differently than those from normal mice. Specifically, there were fewer mesenchymal cells separating the skull bones and the mutant coronal suture was close to fusing.

Hedgehog proteins are growth factors known to guide normal growth and development in a variety of species, including the promotion of bone growth. HHIP is known to inhibit hedgehog activity. To the authors of this study, their results suggest that the HHIP gene reduced hedgehog activity to allow normal development of the coronal suture. They hope that advanced single-cell genetic studies like this one will give researchers a more thorough understanding of how a skull is shaped under healthy and disease conditions.

Who: Greg Holmes, PhD, Assistant Professor of Genetics and Genomic Sciences at Icahn Mount Sinai.

This study was support by the National Institutes of Health (DE024448, DE026814, DE027677, HD078233, and DE030596) and the Scientific Computing group at the Icahn Mount Sinai.

Article

Holmes, G. et al., Single-cell analysis identifies a key role for Hhip in murine coronal suture development. Nature Communications, December 8, 2021, DOI: 10.1038/s41467-021-27402-5


About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across eight hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2023-2024.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.